Skip to main content

Informing the Establishment of the WHO Global Observatory on Health Research and Development

Edited by: Taghreed Adam, John-Arne Røttingen and Marie-Paule Kieny

Return to Health Research Policy and Systems.

This Series is in response to a Call for Papers to inform the establishment of the WHO Global Observatory on Health Research and Development (R&D), with the objective of providing global stakeholders with up-to-date knowledge on methods, analyses and applications to draw from when developing future investment decisions for new health R&D.

The Series Editors declare no conflict of interest. Payment for publication of the Series articles was made by WHO through funding support for the establishment of the WHO Global R&D Observatory. The selection of papers to be included in this Series was made by an external committee of scientific experts. The Journal independently managed the peer-review for the Series papers.

The authors alone are responsible for the views expressed in this Series and they do not necessarily represent the views, decisions or policies of the World Health Organization.

Collection ongoing

  1. A growing number of older adults require complex care, but coordination among professionals to provide comprehensive and high-quality care is perceived to be inadequate. Opportunities to gain the knowledge and...

    Authors: Keiko Nakamura, Kathryn Lizbeth L. Siongco, TJ Robinson T. Moncatar, Lourdes Marie S. Tejero, Shelley Ann F. De La Vega, Sheila R. Bonito, Richard Javier, Takako Tsutsui, Tran Dai Tri Han, Man Thi Hue Vo, Yuri Tashiro, Saber Al-Sobaihi, Kaoruko Seino, Thang Van Vo, Fely Marilyn E. Lorenzo and Carmelita C. Canila
    Citation: Health Research Policy and Systems 2022 20(Suppl 1):111

    This article is part of a Supplement: Volume 20 Supplement 1

  2. Major pharmaceutical companies contribute important expertise to health research and development (R&D), particularly in their ability to develop and bring pharmaceuticals to market. The Access to Medicine Inde...

    Authors: Clarke B. Cole, Stine Trolle and Danny J. Edwards
    Citation: Health Research Policy and Systems 2018 16:73
  3. Recognising radical shifts in the global health research (GHR) environment, participants in a 2013 deliberative dialogue called for careful consideration of equity-centred principles that should inform Canadia...

    Authors: Katrina Plamondon, Dylan Walters, Sandy Campbell and Jennifer Hatfield
    Citation: Health Research Policy and Systems 2017 15:72
  4. We sought to analyse the impacts found, and the methods used, in a series of assessments of programmes and portfolios of health research consisting of multiple projects.

    Authors: Steve Hanney, Trisha Greenhalgh, Amanda Blatch-Jones, Matthew Glover and James Raftery
    Citation: Health Research Policy and Systems 2017 15:26
  5. In recognition of the need for long-term planning for global health research, and to inform future global health research priorities, the United Kingdom Department for International Development (DfID) carried ...

    Authors: David Mc Conalogue, Sue Kinn, Jo-Ann Mulligan and Malcolm McNeil
    Citation: Health Research Policy and Systems 2017 15:24
  6. In 2016, England’s National Institute for Health Research (NIHR) celebrated its tenth anniversary as an innovative national health research system with a focus on meeting patients’ needs. This provides a good ...

    Authors: Stephen R. Hanney and Miguel A. González-Block
    Citation: Health Research Policy and Systems 2016 14:90
  7. Universities are significant contributors to research and technologies in health; however, the health needs of the world’s poor are historically neglected in research. Medical discoveries are frequently licens...

    Authors: Dzintars Gotham, Jonathan Meldrum, Vaitehi Nageshwaran, Christopher Counts, Nina Kumari, Manuel Martin, Ben Beattie and Nathan Post
    Citation: Health Research Policy and Systems 2016 14:76
  8. There is increasing interest amongst donors in investing in the health sectors of fragile and conflict-affected states, although there is limited research evidence and research funding to support this. Agreein...

    Authors: Aniek Woodward, Egbert Sondorp, Sophie Witter and Tim Martineau
    Citation: Health Research Policy and Systems 2016 14:51
  9. National health research for development (R4D) platforms in lower income countries (LICs) are few. The Health Research Capacity Strengthening Initiative (HRCSI, 2008–2013) was a national systems-strengthening ...

    Authors: Donald C. Cole, Lot Jata Nyirenda, Nadia Fazal and Imelda Bates
    Citation: Health Research Policy and Systems 2016 14:24
  10. Little is known about who the main public and philanthropic funders of health research are globally, what they fund and how they decide what gets funded. This study aims to identify the 10 largest public and p...

    Authors: Roderik F. Viergever and Thom C. C. Hendriks
    Citation: Health Research Policy and Systems 2016 14:12
  11. The “Unfinished Agenda” of infectious diseases is of great importance to policymakers and research funding agencies that require ongoing research evidence on their effective management. Journal publications he...

    Authors: Michael G. Head, Joseph R. Fitchett, Gemma Derrick, Fatima B. Wurie, Jonathan Meldrum, Nina Kumari, Benjamin Beattie, Christopher J. Counts and Rifat Atun
    Citation: Health Research Policy and Systems 2015 13:63
  12. In May 2013, the WHO Member States requested the WHO to establish a Global Observatory on Health Research and Development (R&D), as part of a strategic work-plan to promote innovation, build capacity, improve ...

    Authors: Taghreed Adam, John-Arne Røttingen and Marie-Paule Kieny
    Citation: Health Research Policy and Systems 2015 13:9